Mission Produce, Inc. (AVO) Financial Statements
Mission Produce, Inc. (AVO) reported trailing twelve-month revenue of $1.3B (down 6.2% year on year) and net income of $1.6M as of 2026-07-31, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$2.3M.
Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason
AVOMission Produce, Inc.Follow AVO — free
—
Price chart with a free account
- Market cap
- 1.0B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Dec, in 53 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jul 26.
| Line | FY2021 Oct 21 | FY2022 Oct 22 | FY2023 Oct 23 | FY2024 Oct 24 | FY2025 Oct 25 | TTM Jul 26 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue | 0.89 | 1.05 | 0.95 | 1.23 | 1.39 | 1.34 | |
| Gross profit | 0.12 | 0.09 | 0.08 | 0.15 | 0.16 | 0.15 | |
| Operating income | 0.06 | -0.04 | 0.01 | 0.07 | 0.07 | 0.02 | |
| Pre-tax income | 0.07 | -0.03 | -0.00 | 0.06 | 0.06 | 0.02 | |
| Income tax | 0.02 | 0.00 | 0.00 | 0.02 | 0.02 | 0.01 | |
| Net income | 0.04 | -0.03 | -0.00 | 0.04 | 0.04 | 0.00 | |
| Diluted EPS ($) | 0.63 | -0.49 | -0.04 | 0.52 | 0.53 | 0.02 | |
| Diluted shares (bn) | 0.071 | 0.071 | 0.071 | 0.071 | 0.071 | — |
USD billions · SEC XBRL
Mission Produce, Inc. — questions
- What is Mission Produce, Inc.'s revenue?
- $1.3B over the twelve months to 2026-07-31, down 6.2% year on year, from its 10-Q and 10-K filings.
- What is Mission Produce, Inc.'s net income?
- $1.6M over the twelve months to 2026-07-31.
- What is Mission Produce, Inc.'s free cash flow?
- -$2.3M over the twelve months to 2026-07-31.
- What are Mission Produce, Inc.'s diluted earnings per share?
- $0.02 over the twelve months to 2026-07-31.
Every figure on this page comes from Mission Produce, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.